The Clinical Research Department (CRD) at KFSH&RC was established in December 2020 under the patronage of KFSH&RC leadership to promote and facilitate prospective clinical trial activities at KFSH&RC and provide an access for our patients to be enrolled and treated on cutting edge international prospective clinical trials. The department will serve as a centralized bureau to coordinate and supervise the conduct of prospective clinical trials initiated by the institution’s investigators (investigator-initiated trials) or supported by the industry (sponsored-trials). As a centralized office, the department will be the starting point to conduct prospective clinical trials at KFSH&RC. The CRD offers the physical space and experienced multidisciplinary support staff to conduct and complete prospective clinical research at KFSH&RC.
We provide “one-stop-shop” assistance and coordination services for Phase II-IV (soon will include phase I) prospective clinical trials spreading over all sub-specialties of KFSH&RC. The CRD is responsible for reviewing, submitting and following all prospective clinical-trial proposals in compliance with standard guidelines. The CRD will follow and communicate with all the appropriate stakeholders to expedite the submission/approval process. Clinical Research Department at KFSH&RC is committed to protecting the rights, dignity, welfare, and privacy of human subjects.
All clinical research overseen and conducted at KFSH&RC irrespective of funding must be reviewed by the hospital IRB and then to go through local regulators.
To be recognized as a leading global research institute running cutting edge hi-tech and advanced therapeutics trials offering world class clinical solutions and to offer access for the patients to a novel, affordable, safe and effective healthcare solutions and innovative treatments to improve the health and wellness of people everywhere.
Provided by the Sponsored Companies:
Phone: +966114647272 Ext: 73324